Ergomed Clinical Research Limited
Registered name: ERGOMED CLINICAL RESEARCH LIMITED
Part of Permira VIII Investment Platform Limited groupErgomed Clinical Research Limited made £15.1m revenue and £554k profit in the year to 31 Dec 2025.
Ergomed Clinical Research Limited’s revenue fell 18% to £15.1m in the year to 31 Dec 2025, with £554k profit. The company is classified under “other professional, scientific and technical activities” and is based in Guildford; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Guildford
- Age
- 22 yrs · since 2004
- Type
- Private Limited Company
Key figures
Financial history
| Year to | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|
| Disclosure | Profit & loss | Profit & loss | Profit & loss |
| Profit & loss | |||
| Revenue (turnover) | £8.3m | £18.4m | £15.1m |
| Cost of sales | −£7.6m | −£16.8m | −£14.2m |
| Gross profit | £629k | £1.6m | £884k |
| Operating profit | £96.8k | −£124k | £555k |
| Profit before tax | £96.8k | −£124k | £554k |
| Profit after tax | £96.8k | −£124k | £554k |
| Profit (best available) | £96.8k | −£124k | £554k |
| Employees (average) | — | — | — |
| Ratios | |||
| Profit margin | 1.2% | −0.7% | 3.7% |
| Gross margin | 7.6% | 8.7% | 5.9% |
| Growth (year on year) | |||
| Revenue growth | — | ▲123% | ▼18.1% |
| Profit growth | — | ▼227.7% | — |
| Balance sheet — indirect signals, not revenue | |||
| Net assets | — | — | — |
| Source | Accounts · bulk data Oct 2025 | Accounts · bulk data Oct 2025 | Accounts · bulk data Oct 2026 |
How the business works
- Profit margin
- 3.7%
- Profit ÷ revenue.
- Gross margin
- 5.9%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- —
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- —
- Now —
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Permira VIII Investment Platform Limitedultimate parent75–100%
- Eightplatform V Limited75–100%
- Eden Topco Limited75–100%
- Eden Holdco 1 Limited75–100%
- Eden Holdco 2 Limited75–100%
- Eden Holdco 3 Limited75–100%
- Eden Acquisitionco Limited75–100%
- Ergomed Group Limited75–100%
- Ergomed Clinical Research Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Sister companies (4)
- Adamas Consulting Group LimitedFigures not disclosed
- Ergomed US Holdings LimitedFigures not disclosed
- Haemostatix LimitedFigures not disclosed
- Primevigilance LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from accounts for the year to 31 Dec 2025 (profit £554k), from the Companies House accounts bulk data published Oct 2026. Spotted an error? Request a correction.
Updated from Companies House on 25 Oct 2026